Your English writing platform
Discover LudwigExact(1)
In the absence of evidence of the efficacy of regimen D started after 28 weeks but before 36 weeks of gestation, we assume the same efficacy if treatment is started before 34 weeks, and the lower efficacy of regimen A for those starting after 34 weeks.
Similar(59)
We predict the efficacy of regimens containing different doses and frequencies of isoniazid and rifampin.
We particularly analyzed the efficacy of regimens: G vs. F and with P vs. without P.
We analyzed the efficacy of regimens: gemcitabine (G) versus fluoropyrimidine (F) and with or without platinum (P).
However, it is hard to compare directly the efficacy of regimens because the classifications of chemotherapy regimens in both studies were different.
The comparable efficacy of regimens substituting capecitabine for infused 5-flurouracil has been directly studied in two phase III trials: the REAL-2 study and the ML17032 study.
The precise efficacy of this regimen, and the subgroup of gastric cancer patients who benefit more from this regimen need to be investigated by a large-scale study.
To compare the efficacy of a regimen combining mental practice (MP) with overground training (OT) with the efficacy of a regimen consisting of OT only on gait velocity and lower extremity motor outcomes in individuals with chronic (>12mo postinjury), incomplete spinal cord injury (SCI).
busulfan has significantly improved the tolerability and efficacy of this regimen.
A phase 2 trial is necessary to better delineate the antimyeloma efficacy of this regimen.
However, only 4 of all 22 treated patients had either chemotherapy refractory lymphoma or lymphoma that had relapsed after autologous stem cell transplant, undoubtedly comprising the significant efficacy of this regimen.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com